Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Chronic prostatitis
CUI: C0085696
Disease: Chronic prostatitis
1 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2017 2017
Juvenile idiopathic arthritis, enthesitis related arthritis
1 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2014 2014
Fuchs' heterochromic cyclitis
CUI: C0016782
Disease: Fuchs' heterochromic cyclitis
3 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1 2012 2012
Kaposi's sarcoma classical type
CUI: C0279084
Disease: Kaposi's sarcoma classical type
3 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2016 2016
Benign neoplasm of thyroid gland
CUI: C0154038
Disease: Benign neoplasm of thyroid gland
4 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2013 2013
hiv-infection/aids
CUI: C0497169
Disease: hiv-infection/aids
4 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2019 2019
Urologic Neoplasms
CUI: C0042076
Disease: Urologic Neoplasms
4 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2018 2018
Diabetic macular edema
CUI: C0730285
Disease: Diabetic macular edema
6 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2016 2016
stage, non-small cell lung cancer
CUI: C0280217
Disease: stage, non-small cell lung cancer
6 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2013 2013
Autoimmune thrombocytopenia
CUI: C0242584
Disease: Autoimmune thrombocytopenia
7 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2014 2014
Thrombocytopenia due to platelet alloimmunization
7 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2014 2014
trachomatis
CUI: C4290046
Disease: trachomatis
7 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2009 2009
Mixed follicular and papillary thyroid carcinoma
8 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2018 2018
Juvenile rheumatoid arthritis
CUI: C3714757
Disease: Juvenile rheumatoid arthritis
10 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.020 0.500 2 2012 2019
Cancer of Urinary Tract
CUI: C0751571
Disease: Cancer of Urinary Tract
11 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2017 2017
OROFACIAL CLEFT 1
CUI: C1861537
Disease: OROFACIAL CLEFT 1
11 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2018 2018
Malignant Squamous Cell Neoplasm
CUI: C0751688
Disease: Malignant Squamous Cell Neoplasm
12 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2017 2017
Cancer of Digestive System
CUI: C0751075
Disease: Cancer of Digestive System
15 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.020 1.000 2 2014 2017
Diabetic Polyneuropathies
CUI: C0271680
Disease: Diabetic Polyneuropathies
16 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2014 2014
Fatal Familial Insomnia
CUI: C0206042
Disease: Fatal Familial Insomnia
16 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2018 2018
Oral Cavity Carcinoma
CUI: C0151546
Disease: Oral Cavity Carcinoma
16 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2012 2012
Bronchial Hyperreactivity
CUI: C0085129
Disease: Bronchial Hyperreactivity
18 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2016 2016
Liver Failure
CUI: C0085605
Disease: Liver Failure
20 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2013 2013
Gastritis
CUI: C0017152
Disease: Gastritis
21 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.010 1.000 1 2010 2010
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
24 0.447 0.880 5 160485411 mature miRNA variant C/G snv 0.71; 4.1E-06 0.70 0.020 1.000 2 2010 2011